XML 19 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
PAY VERSUS PERFORMANCE
2024 PAY VERSUS PERFORMANCE
Year(1)
​ ​
Summary
Compensation
Table Total
for PEO
($)(2)
​ ​
Compensation
Actually Paid
to PEO
($)(3)
​ ​
Average
Summary
Compensation
Table Total
for Non-PEO
NEOs
($)(2)
​ ​
Average
Compensation
Actually Paid
to Non-PEO
NEOs
($)(3)
​ ​
Value of Initial Fixed $100
Investment Based On:(4)
​ ​
Net
Income
(Loss)
($)
​ ​
Non-GAAP
EBITDA(6)
($)
​
​
Total
Shareholder
Return
($)
​ ​
Peer Group
Total
Shareholder
Return
($)(5)
​
2024
​ ​ ​ ​ 8,174,639 ​ ​ ​ ​ ​ 14,846,903 ​ ​ ​ ​ ​ 2,863,738 ​ ​ ​ ​ ​ 4,309,265 ​ ​ ​ ​ ​ 54.48 ​ ​ ​ ​ ​ 84.53 ​ ​ ​ ​ ​ 12,531,000 ​ ​ ​ ​ ​ 135,775,000 ​ ​
2023
​ ​ ​ ​ 11,022,072 ​ ​ ​ ​ ​ 4,283,137 ​ ​ ​ ​ ​ 2,960,737 ​ ​ ​ ​ ​ 2,707,080 ​ ​ ​ ​ ​ 46.05 ​ ​ ​ ​ ​ 86.74 ​ ​ ​ ​ ​ (20,371,000) ​ ​ ​ ​ ​ 137,885,000 ​ ​
2022
​ ​ ​ ​ 7,902,397 ​ ​ ​ ​ ​ (13,263,924) ​ ​ ​ ​ ​ 2,420,898 ​ ​ ​ ​ ​ (2,970,567) ​ ​ ​ ​ ​ 61.70 ​ ​ ​ ​ ​ 86.04 ​ ​ ​ ​ ​ 5,648,000 ​ ​ ​ ​ ​ 192,885,000 ​ ​
2021
​ ​ ​ ​ 8,437,413 ​ ​ ​ ​ ​ 23,007,852 ​ ​ ​ ​ ​ 3,380,842 ​ ​ ​ ​ ​ 7,279,179 ​ ​ ​ ​ ​ 220.80 ​ ​ ​ ​ ​ 114.41 ​ ​ ​ ​ ​ 77,849,000 ​ ​ ​ ​ ​ 229,617,000 ​ ​
2020
​ ​ ​ ​ 8,028,508 ​ ​ ​ ​ ​ 15,533,481 ​ ​ ​ ​ ​ 2,250,868 ​ ​ ​ ​ ​ 4,029,011 ​ ​ ​ ​ ​ 146.87 ​ ​ ​ ​ ​ 127.18 ​ ​ ​ ​ ​ 32,194,000 ​ ​ ​ ​ ​ 159,388,000 ​ ​
​
(1)
Mr. Lipps served as the Company’s principal executive officer for the entirety of 2020, 2021, 2022, 2023, and 2024 and the Company’s other NEOs for the applicable years were as follows:
​
2024: Nnamdi Njoku, Nchacha E. Etta, and Corey J. Manley
2023: Nchacha E. Etta; Corey J. Manley; Peter J. Kuipers; Scott P. Seidelmann; and Christine Mellon.
2022: Peter J. Kuipers; Scott P. Seidelmann; Christine Mellon, Corey J. Manley and Dan S. Johnston.
2021: Peter J. Kuipers; Scott P. Seidelmann; Dan S. Johnston; and Christine Mellon.
2020: Peter J. Kuipers; Scott P. Seidelmann; Dan S. Johnston; and Nhat H. Ngo.
(2)
Amounts reported in this column represent (i) the total compensation reported in the Summary Compensation Table for the applicable year in the case of Mr. Lipps and (ii) the average of the total compensation reported in the Summary Compensation Table for the applicable year for the Company’s NEOs reported for the applicable year other than Mr. Lipps.
​
(3)
To calculate compensation actually paid, adjustments were made to the amounts reported in the Summary Compensation Table for the applicable year. A reconciliation of the adjustments for Mr. Lipps and for the average of the other NEOs is set forth following the footnotes to this table.
​
(4)
Pursuant to rules of the SEC, the comparison assumes $100 was invested on December 31, 2019. Historic stock price performance is not indicative of future stock price performance.
​
(5)
The TSR Peer Group consists of the NASDAQ Health Care Index, an independently prepared index that includes companies in the healthcare industry.
​
(6)
As noted in the CD&A, for 2024, the Compensation Committee determined that non-GAAP EBITDA is a core driver of the Company’s performance and stockholder value creation and, accordingly, was utilized as a component for the annual performance-based cash bonus awards. Under the annual performance-based cash bonus awards, non-GAAP EBITDA for incentive purposes represents the Company’s as-reported non-GAAP EBITDA for each quarter and is defined as earnings before interest
​
income and expense, taxes, depreciation, amortization, and share-based compensation expenses pursuant to ASC Topic 718, as well as excluding certain other non-GAAP adjustments such as acquisition-related expenses, impairment and abandonment of operating lease right-of-use and other assets related to facilities, severance-related expenses, amortization of debt issuance costs, restructuring expenses, executive transition costs, ransomware-related insurance recoveries, legal and regulatory expenses, management severance costs, and gains on extinguishment of convertible senior notes, net.
Compensation Actually Paid Adjustments
​ ​ ​ ​ ​ ​ ​ ​ ​
Minus
​ ​
Plus
​ ​
Plus/(Minus)
​ ​
Plus
​ ​
Plus/(Minus)
​ ​
Minus
​ ​
Plus
​ ​
Equals
​
Year
​ ​
Summary
Compensation
Table Total
($)(a)
​ ​
Grant
Date Fair
Value of
Stock
Option
and Stock
Awards
Granted
in Fiscal
Year
($)(b)
​ ​
Fair Value
at Fiscal
Year-End of
Outstanding
and
Unvested
Stock
Option and
Stock
Awards
Granted in
Fiscal Year
($)(c)
​ ​
Change in
Fair
Value of
Outstanding
and
Unvested
Stock
Option and
Stock
Awards
Granted in
Prior Fiscal
Years
($)(d)
​ ​
Fair
Value at
Vesting
of Stock
Option
and Stock
Awards
Granted
in Fiscal
Year that
Vested
During
Fiscal
Year
($)(e)
​ ​
Change in
Fair Value
as of Vesting
Date of
Stock
Option and
Stock
Awards
Granted in
Prior Fiscal
Years for
which
Applicable
Vesting
Conditions
Were
Satisfied
During
Fiscal Year
($)(f)
​ ​
Fair Value
as of Prior
Fiscal Year-
End of
Stock
Option and
Stock Awards
Granted in
Prior Fiscal
Years that
Failed to
Meet
Applicable
Vesting
Conditions
During
Fiscal Year
($)(g)
​ ​
Changes in
Fair Value to
Reflect
Excess Fair
Value
Resulting
From
Modifications
to Stock
Option and
Stock Awards
($)(h)
​ ​
Compensation
Actually Paid
​
Randall A. Lipps ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
2024
​ ​ ​ ​ 8,174,639 ​ ​ ​ ​ ​ (6,009,274) ​ ​ ​ ​ ​ 13,625,167 ​ ​ ​ ​ ​ 222,306 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 96,805 ​ ​ ​ ​ ​ (1,262,740) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 14,846,903 ​ ​
2023
​ ​ ​ ​ 11,022,072 ​ ​ ​ ​ ​ (9,174,870) ​ ​ ​ ​ ​ 3,031,350 ​ ​ ​ ​ ​ (312,629) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 164,437 ​ ​ ​ ​ ​ (447,223) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,283,137 ​ ​
2022
​ ​ ​ ​ 7,902,397 ​ ​ ​ ​ ​ (6,699,022) ​ ​ ​ ​ ​ 1,328,514 ​ ​ ​ ​ ​ (8,414,632) ​ ​ ​ ​ ​ 470,595 ​ ​ ​ ​ ​ (7,851,777) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ (13,263,924) ​ ​
2021
​ ​ ​ ​ 8,437,413 ​ ​ ​ ​ ​ (6,001,550) ​ ​ ​ ​ ​ 10,175,965 ​ ​ ​ ​ ​ 5,991,052 ​ ​ ​ ​ ​ 830,085 ​ ​ ​ ​ ​ 3,574,887 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 23,007,852 ​ ​
2020
​ ​ ​ ​ 8,028,508 ​ ​ ​ ​ ​ (6,050,819) ​ ​ ​ ​ ​ 9,040,517 ​ ​ ​ ​ ​ 4,238,153 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 277,122 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 15,533,481 ​ ​
Other NEOs(i) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
2024
​ ​ ​ ​ 2,863,738 ​ ​ ​ ​ ​ (2,118,720) ​ ​ ​ ​ ​ 3,750,796 ​ ​ ​ ​ ​ 76,171 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 36,350 ​ ​ ​ ​ ​ (299,070) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,309,265 ​ ​
2023
​ ​ ​ ​ 2,960,737 ​ ​ ​ ​ ​ (1,404,150) ​ ​ ​ ​ ​ 1,408,170 ​ ​ ​ ​ ​ (43,870) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 72,948 ​ ​ ​ ​ ​ (402,639) ​ ​ ​ ​ ​ 115,884 ​ ​ ​ ​ ​ 2,707,080 ​ ​
2022
​ ​ ​ ​ 2,420,898 ​ ​ ​ ​ ​ (1,879,383) ​ ​ ​ ​ ​ 326,852 ​ ​ ​ ​ ​ (1,698,012) ​ ​ ​ ​ ​ 131,140 ​ ​ ​ ​ ​ (1,607,035) ​ ​ ​ ​ ​ (665,026) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ (2,970,567) ​ ​
2021
​ ​ ​ ​ 3,380,842 ​ ​ ​ ​ ​ (2,374,967) ​ ​ ​ ​ ​ 3,930,801 ​ ​ ​ ​ ​ 1,229,594 ​ ​ ​ ​ ​ 363,110 ​ ​ ​ ​ ​ 749,800 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 7,279,179 ​ ​
2020
​ ​ ​ ​ 2,250,868 ​ ​ ​ ​ ​ (1,355,693) ​ ​ ​ ​ ​ 1,837,660 ​ ​ ​ ​ ​ 1,127,068 ​ ​ ​ ​ ​ 101,699 ​ ​ ​ ​ ​ 67,408 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,029,011 ​ ​
​
(a)
Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year. With respect to the other NEOs, amounts shown represent averages.
​
(b)
Represents the grant date fair value of the stock option and stock awards granted during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes and, in the case of awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the applicable date.
​
(c)
Represents the fair value as of the indicated fiscal year-end of the outstanding and unvested option awards and stock awards granted during such fiscal year, computed in accordance with the methodology used for financial reporting purposes and, in the case of awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the applicable date.
​
(d)
Represents the change in fair value during the indicated fiscal year of each option award and stock award that was granted in a prior fiscal year and that remained outstanding and unvested as of the last
day of the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year.
(e)
Represents the fair value at vesting of the option awards and stock awards that were granted and vested during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(f)
Represents the change in fair value, measured from the prior fiscal year-end to the vesting date, of each option award and stock award that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(g)
Represents the fair value as of the last day of the prior fiscal year of the option award and stock awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(h)
Represents the excess fair value, if any, of modified option awards over the fair value of the original awards as of the modification and which are not otherwise reflected in the other columns in this table.
(i)
See footnote 1 above for the NEOs included in the average for each year.
       
Company Selected Measure Name Non-GAAP EBITDA        
Named Executive Officers, Footnote
(1)
Mr. Lipps served as the Company’s principal executive officer for the entirety of 2020, 2021, 2022, 2023, and 2024 and the Company’s other NEOs for the applicable years were as follows:
​
2024: Nnamdi Njoku, Nchacha E. Etta, and Corey J. Manley
2023: Nchacha E. Etta; Corey J. Manley; Peter J. Kuipers; Scott P. Seidelmann; and Christine Mellon.
2022: Peter J. Kuipers; Scott P. Seidelmann; Christine Mellon, Corey J. Manley and Dan S. Johnston.
2021: Peter J. Kuipers; Scott P. Seidelmann; Dan S. Johnston; and Christine Mellon.
2020: Peter J. Kuipers; Scott P. Seidelmann; Dan S. Johnston; and Nhat H. Ngo.
       
Peer Group Issuers, Footnote
(5)
The TSR Peer Group consists of the NASDAQ Health Care Index, an independently prepared index that includes companies in the healthcare industry.
       
PEO Total Compensation Amount $ 8,174,639 $ 11,022,072 $ 7,902,397 $ 8,437,413 $ 8,028,508
PEO Actually Paid Compensation Amount $ 14,846,903 4,283,137 (13,263,924) 23,007,852 15,533,481
Adjustment To PEO Compensation, Footnote
Compensation Actually Paid Adjustments
​ ​ ​ ​ ​ ​ ​ ​ ​
Minus
​ ​
Plus
​ ​
Plus/(Minus)
​ ​
Plus
​ ​
Plus/(Minus)
​ ​
Minus
​ ​
Plus
​ ​
Equals
​
Year
​ ​
Summary
Compensation
Table Total
($)(a)
​ ​
Grant
Date Fair
Value of
Stock
Option
and Stock
Awards
Granted
in Fiscal
Year
($)(b)
​ ​
Fair Value
at Fiscal
Year-End of
Outstanding
and
Unvested
Stock
Option and
Stock
Awards
Granted in
Fiscal Year
($)(c)
​ ​
Change in
Fair
Value of
Outstanding
and
Unvested
Stock
Option and
Stock
Awards
Granted in
Prior Fiscal
Years
($)(d)
​ ​
Fair
Value at
Vesting
of Stock
Option
and Stock
Awards
Granted
in Fiscal
Year that
Vested
During
Fiscal
Year
($)(e)
​ ​
Change in
Fair Value
as of Vesting
Date of
Stock
Option and
Stock
Awards
Granted in
Prior Fiscal
Years for
which
Applicable
Vesting
Conditions
Were
Satisfied
During
Fiscal Year
($)(f)
​ ​
Fair Value
as of Prior
Fiscal Year-
End of
Stock
Option and
Stock Awards
Granted in
Prior Fiscal
Years that
Failed to
Meet
Applicable
Vesting
Conditions
During
Fiscal Year
($)(g)
​ ​
Changes in
Fair Value to
Reflect
Excess Fair
Value
Resulting
From
Modifications
to Stock
Option and
Stock Awards
($)(h)
​ ​
Compensation
Actually Paid
​
Randall A. Lipps ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
2024
​ ​ ​ ​ 8,174,639 ​ ​ ​ ​ ​ (6,009,274) ​ ​ ​ ​ ​ 13,625,167 ​ ​ ​ ​ ​ 222,306 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 96,805 ​ ​ ​ ​ ​ (1,262,740) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 14,846,903 ​ ​
2023
​ ​ ​ ​ 11,022,072 ​ ​ ​ ​ ​ (9,174,870) ​ ​ ​ ​ ​ 3,031,350 ​ ​ ​ ​ ​ (312,629) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 164,437 ​ ​ ​ ​ ​ (447,223) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,283,137 ​ ​
2022
​ ​ ​ ​ 7,902,397 ​ ​ ​ ​ ​ (6,699,022) ​ ​ ​ ​ ​ 1,328,514 ​ ​ ​ ​ ​ (8,414,632) ​ ​ ​ ​ ​ 470,595 ​ ​ ​ ​ ​ (7,851,777) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ (13,263,924) ​ ​
2021
​ ​ ​ ​ 8,437,413 ​ ​ ​ ​ ​ (6,001,550) ​ ​ ​ ​ ​ 10,175,965 ​ ​ ​ ​ ​ 5,991,052 ​ ​ ​ ​ ​ 830,085 ​ ​ ​ ​ ​ 3,574,887 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 23,007,852 ​ ​
2020
​ ​ ​ ​ 8,028,508 ​ ​ ​ ​ ​ (6,050,819) ​ ​ ​ ​ ​ 9,040,517 ​ ​ ​ ​ ​ 4,238,153 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 277,122 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 15,533,481 ​ ​
Other NEOs(i) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
2024
​ ​ ​ ​ 2,863,738 ​ ​ ​ ​ ​ (2,118,720) ​ ​ ​ ​ ​ 3,750,796 ​ ​ ​ ​ ​ 76,171 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 36,350 ​ ​ ​ ​ ​ (299,070) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,309,265 ​ ​
2023
​ ​ ​ ​ 2,960,737 ​ ​ ​ ​ ​ (1,404,150) ​ ​ ​ ​ ​ 1,408,170 ​ ​ ​ ​ ​ (43,870) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 72,948 ​ ​ ​ ​ ​ (402,639) ​ ​ ​ ​ ​ 115,884 ​ ​ ​ ​ ​ 2,707,080 ​ ​
2022
​ ​ ​ ​ 2,420,898 ​ ​ ​ ​ ​ (1,879,383) ​ ​ ​ ​ ​ 326,852 ​ ​ ​ ​ ​ (1,698,012) ​ ​ ​ ​ ​ 131,140 ​ ​ ​ ​ ​ (1,607,035) ​ ​ ​ ​ ​ (665,026) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ (2,970,567) ​ ​
2021
​ ​ ​ ​ 3,380,842 ​ ​ ​ ​ ​ (2,374,967) ​ ​ ​ ​ ​ 3,930,801 ​ ​ ​ ​ ​ 1,229,594 ​ ​ ​ ​ ​ 363,110 ​ ​ ​ ​ ​ 749,800 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 7,279,179 ​ ​
2020
​ ​ ​ ​ 2,250,868 ​ ​ ​ ​ ​ (1,355,693) ​ ​ ​ ​ ​ 1,837,660 ​ ​ ​ ​ ​ 1,127,068 ​ ​ ​ ​ ​ 101,699 ​ ​ ​ ​ ​ 67,408 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,029,011 ​ ​
​
(a)
Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year. With respect to the other NEOs, amounts shown represent averages.
​
(b)
Represents the grant date fair value of the stock option and stock awards granted during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes and, in the case of awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the applicable date.
​
(c)
Represents the fair value as of the indicated fiscal year-end of the outstanding and unvested option awards and stock awards granted during such fiscal year, computed in accordance with the methodology used for financial reporting purposes and, in the case of awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the applicable date.
​
(d)
Represents the change in fair value during the indicated fiscal year of each option award and stock award that was granted in a prior fiscal year and that remained outstanding and unvested as of the last
day of the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year.
(e)
Represents the fair value at vesting of the option awards and stock awards that were granted and vested during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(f)
Represents the change in fair value, measured from the prior fiscal year-end to the vesting date, of each option award and stock award that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(g)
Represents the fair value as of the last day of the prior fiscal year of the option award and stock awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(h)
Represents the excess fair value, if any, of modified option awards over the fair value of the original awards as of the modification and which are not otherwise reflected in the other columns in this table.
(i)
See footnote 1 above for the NEOs included in the average for each year.
       
Non-PEO NEO Average Total Compensation Amount $ 2,863,738 2,960,737 2,420,898 3,380,842 2,250,868
Non-PEO NEO Average Compensation Actually Paid Amount $ 4,309,265 2,707,080 (2,970,567) 7,279,179 4,029,011
Adjustment to Non-PEO NEO Compensation Footnote
Compensation Actually Paid Adjustments
​ ​ ​ ​ ​ ​ ​ ​ ​
Minus
​ ​
Plus
​ ​
Plus/(Minus)
​ ​
Plus
​ ​
Plus/(Minus)
​ ​
Minus
​ ​
Plus
​ ​
Equals
​
Year
​ ​
Summary
Compensation
Table Total
($)(a)
​ ​
Grant
Date Fair
Value of
Stock
Option
and Stock
Awards
Granted
in Fiscal
Year
($)(b)
​ ​
Fair Value
at Fiscal
Year-End of
Outstanding
and
Unvested
Stock
Option and
Stock
Awards
Granted in
Fiscal Year
($)(c)
​ ​
Change in
Fair
Value of
Outstanding
and
Unvested
Stock
Option and
Stock
Awards
Granted in
Prior Fiscal
Years
($)(d)
​ ​
Fair
Value at
Vesting
of Stock
Option
and Stock
Awards
Granted
in Fiscal
Year that
Vested
During
Fiscal
Year
($)(e)
​ ​
Change in
Fair Value
as of Vesting
Date of
Stock
Option and
Stock
Awards
Granted in
Prior Fiscal
Years for
which
Applicable
Vesting
Conditions
Were
Satisfied
During
Fiscal Year
($)(f)
​ ​
Fair Value
as of Prior
Fiscal Year-
End of
Stock
Option and
Stock Awards
Granted in
Prior Fiscal
Years that
Failed to
Meet
Applicable
Vesting
Conditions
During
Fiscal Year
($)(g)
​ ​
Changes in
Fair Value to
Reflect
Excess Fair
Value
Resulting
From
Modifications
to Stock
Option and
Stock Awards
($)(h)
​ ​
Compensation
Actually Paid
​
Randall A. Lipps ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
2024
​ ​ ​ ​ 8,174,639 ​ ​ ​ ​ ​ (6,009,274) ​ ​ ​ ​ ​ 13,625,167 ​ ​ ​ ​ ​ 222,306 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 96,805 ​ ​ ​ ​ ​ (1,262,740) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 14,846,903 ​ ​
2023
​ ​ ​ ​ 11,022,072 ​ ​ ​ ​ ​ (9,174,870) ​ ​ ​ ​ ​ 3,031,350 ​ ​ ​ ​ ​ (312,629) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 164,437 ​ ​ ​ ​ ​ (447,223) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,283,137 ​ ​
2022
​ ​ ​ ​ 7,902,397 ​ ​ ​ ​ ​ (6,699,022) ​ ​ ​ ​ ​ 1,328,514 ​ ​ ​ ​ ​ (8,414,632) ​ ​ ​ ​ ​ 470,595 ​ ​ ​ ​ ​ (7,851,777) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ (13,263,924) ​ ​
2021
​ ​ ​ ​ 8,437,413 ​ ​ ​ ​ ​ (6,001,550) ​ ​ ​ ​ ​ 10,175,965 ​ ​ ​ ​ ​ 5,991,052 ​ ​ ​ ​ ​ 830,085 ​ ​ ​ ​ ​ 3,574,887 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 23,007,852 ​ ​
2020
​ ​ ​ ​ 8,028,508 ​ ​ ​ ​ ​ (6,050,819) ​ ​ ​ ​ ​ 9,040,517 ​ ​ ​ ​ ​ 4,238,153 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 277,122 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 15,533,481 ​ ​
Other NEOs(i) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
2024
​ ​ ​ ​ 2,863,738 ​ ​ ​ ​ ​ (2,118,720) ​ ​ ​ ​ ​ 3,750,796 ​ ​ ​ ​ ​ 76,171 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 36,350 ​ ​ ​ ​ ​ (299,070) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,309,265 ​ ​
2023
​ ​ ​ ​ 2,960,737 ​ ​ ​ ​ ​ (1,404,150) ​ ​ ​ ​ ​ 1,408,170 ​ ​ ​ ​ ​ (43,870) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 72,948 ​ ​ ​ ​ ​ (402,639) ​ ​ ​ ​ ​ 115,884 ​ ​ ​ ​ ​ 2,707,080 ​ ​
2022
​ ​ ​ ​ 2,420,898 ​ ​ ​ ​ ​ (1,879,383) ​ ​ ​ ​ ​ 326,852 ​ ​ ​ ​ ​ (1,698,012) ​ ​ ​ ​ ​ 131,140 ​ ​ ​ ​ ​ (1,607,035) ​ ​ ​ ​ ​ (665,026) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ (2,970,567) ​ ​
2021
​ ​ ​ ​ 3,380,842 ​ ​ ​ ​ ​ (2,374,967) ​ ​ ​ ​ ​ 3,930,801 ​ ​ ​ ​ ​ 1,229,594 ​ ​ ​ ​ ​ 363,110 ​ ​ ​ ​ ​ 749,800 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 7,279,179 ​ ​
2020
​ ​ ​ ​ 2,250,868 ​ ​ ​ ​ ​ (1,355,693) ​ ​ ​ ​ ​ 1,837,660 ​ ​ ​ ​ ​ 1,127,068 ​ ​ ​ ​ ​ 101,699 ​ ​ ​ ​ ​ 67,408 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,029,011 ​ ​
​
(a)
Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year. With respect to the other NEOs, amounts shown represent averages.
​
(b)
Represents the grant date fair value of the stock option and stock awards granted during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes and, in the case of awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the applicable date.
​
(c)
Represents the fair value as of the indicated fiscal year-end of the outstanding and unvested option awards and stock awards granted during such fiscal year, computed in accordance with the methodology used for financial reporting purposes and, in the case of awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the applicable date.
​
(d)
Represents the change in fair value during the indicated fiscal year of each option award and stock award that was granted in a prior fiscal year and that remained outstanding and unvested as of the last
day of the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year.
(e)
Represents the fair value at vesting of the option awards and stock awards that were granted and vested during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(f)
Represents the change in fair value, measured from the prior fiscal year-end to the vesting date, of each option award and stock award that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(g)
Represents the fair value as of the last day of the prior fiscal year of the option award and stock awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(h)
Represents the excess fair value, if any, of modified option awards over the fair value of the original awards as of the modification and which are not otherwise reflected in the other columns in this table.
(i)
See footnote 1 above for the NEOs included in the average for each year.
       
Compensation Actually Paid vs. Total Shareholder Return
[MISSING IMAGE: lc_ttlshrholret-bw.jpg]
       
Compensation Actually Paid vs. Net Income
[MISSING IMAGE: lc_netincome-bw.jpg]
       
Compensation Actually Paid vs. Company Selected Measure
[MISSING IMAGE: lc_ebitda-bw.jpg]
       
Total Shareholder Return Vs Peer Group [MISSING IMAGE: lc_ttlshrholret-bw.jpg]        
Tabular List, Table
Performance Measures Used to Link Company Performance and Compensation Actually Paid to the NEOs
Below is a list of performance measures, which in the Company’s assessment represent the most important performance measures used by the Company to link compensation actually paid to the NEOs for 2024. Please see the CD&A for further information regarding how each of these measures is used in the Company’s executive compensation program.
•
Non-GAAP EBITDA
​
•
SaaS and Expert Services Revenue
​
•
Total Revenue
​
•
Relative Total Shareholder Return
​
•
Stock Price
​
​
        
Total Shareholder Return Amount $ 54.48 46.05 61.7 220.8 146.87
Peer Group Total Shareholder Return Amount 84.53 86.74 86.04 114.41 127.18
Net Income (Loss) $ 12,531,000 $ (20,371,000) $ 5,648,000 $ 77,849,000 $ 32,194,000
Company Selected Measure Amount 135,775,000 137,885,000 192,885,000 229,617,000 159,388,000
PEO Name Mr. Lipps        
Measure:: 1          
Pay vs Performance Disclosure          
Name Non-GAAP EBITDA        
Non-GAAP Measure Description
(6)
As noted in the CD&A, for 2024, the Compensation Committee determined that non-GAAP EBITDA is a core driver of the Company’s performance and stockholder value creation and, accordingly, was utilized as a component for the annual performance-based cash bonus awards. Under the annual performance-based cash bonus awards, non-GAAP EBITDA for incentive purposes represents the Company’s as-reported non-GAAP EBITDA for each quarter and is defined as earnings before interest
​
income and expense, taxes, depreciation, amortization, and share-based compensation expenses pursuant to ASC Topic 718, as well as excluding certain other non-GAAP adjustments such as acquisition-related expenses, impairment and abandonment of operating lease right-of-use and other assets related to facilities, severance-related expenses, amortization of debt issuance costs, restructuring expenses, executive transition costs, ransomware-related insurance recoveries, legal and regulatory expenses, management severance costs, and gains on extinguishment of convertible senior notes, net.
       
Measure:: 2          
Pay vs Performance Disclosure          
Name SaaS and Expert Services Revenue        
Measure:: 3          
Pay vs Performance Disclosure          
Name Total Revenue        
Measure:: 4          
Pay vs Performance Disclosure          
Name Relative Total Shareholder Return        
Measure:: 5          
Pay vs Performance Disclosure          
Name Stock Price        
PEO | Pension Adjustments Prior Service Cost          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (6,009,274) $ (9,174,870) $ (6,699,022) $ (6,001,550) $ (6,050,819)
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 13,625,167 3,031,350 1,328,514 10,175,965 9,040,517
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 222,306 (312,629) (8,414,632) 5,991,052 4,238,153
PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 470,595 830,085
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 96,805 164,437 (7,851,777) 3,574,887 277,122
PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (1,262,740) (447,223)
PEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount
Non-PEO NEO | Pension Adjustments Prior Service Cost          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (2,118,720) (1,404,150) (1,879,383) (2,374,967) (1,355,693)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 3,750,796 1,408,170 326,852 3,930,801 1,837,660
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 76,171 (43,870) (1,698,012) 1,229,594 1,127,068
Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 131,140 363,110 101,699
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 36,350 72,948 (1,607,035) 749,800 67,408
Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (299,070) (402,639) (665,026)
Non-PEO NEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 115,884